We previously showed that human melanoma, CHO and other cells can convert /3-xylosides into structural analogs of ganglioside G MV We have investigated several potential acceptors including a series of n-alkyl-/3-D-glucosides (n = 6-9). All were labeled with 3 H-galactose when incubated with human melanoma cells. Octyl-j3-D-glucoside (Glc/3Octyl) was the best acceptor, whereas neither octyla-D-glucoside nor JV-octanoyl-methylglucamine (MEGA 8) were labeled. Analysis of the products by a combination of chromatographic methods and specific enzyme digestions showed that the acceptors first received a single Gal/31,4 residue followed by an «2,3 linked sialic acid. Synthesis of these products did not affect cell viability, adherence, protein biosynthesis, or incorporation of radiolabeled precursors into glycoprotein, glycolipid or proteoglycans. To determine which /31,4 galactosyl transferase synthesized Gal/31,4Glc/3Octyl, we analyzed similar incubations using CHO cells and a mutant CHO line (CHO 761) which lacks GAG-core specific filA galactosyltransferase. The mutant cells showed the same level of incorporation as the control, eliminating this enzyme as a candidate. Thermal inactivation kinetics using melanoma cell microsomes and rat liver Golgi to galactosylate Glc/3Octyl showed the same half-life as UDP-Gal:GlcNAc /31,4 galactosyltransferase, whereas LacCer synthase was inactivated at a much faster rate. We show that Glc/3Octyl is a substrate for purified bovine milk UDP-Gal:GlcNAc /31,4 galactosyltransferase Furthermore, the galactosylation of Glc/3Octyl by CHO cell microsomes can be competitively inhibited by GlcNAc or GlcNAc/3MU . These results indicate that UDP-Gal:GlcNAc /31,4 galactosyltransferase is the enzyme used for the synthesis of the alkyl lactosides when cells or rat liver Golgi are incubated with alkyl p glucosides.
Introduction
/3-Xylosides are well-known inhibitors of proteoglycan synthesis and serve as alternate acceptors for the assembly of GAG chains. Similarly, various GalNAc a-aryl compounds can prime O-linked oligosaccharide chain synthesis and lead to inhibition of O-linked oligosaccharide synthesis (Kuan et al 1989 , Zhuang et al, 1991 Huang et al, 1992; Dennis et al, 1993 , Dilulio, 1995 . In both cases, a variety of aglycones have been used. We previously showed that several different cell lines including human melanoma, human leukemia, and Chinese hamster ovary cells use Xyl/3pNp or Xyl/3MU as acceptors for the addition of galactose and sialic acid to form a molecule that resembles ganglioside GM3: Siao:2,3Gal/31,4Xyl-aglycone (Freeze et al, 1993) . Synthesis of this unexpected product seems relatively specific for /3-Xyloside, since a-Xyloside is only galactosylated not sialylated, and Glc/3MU is not modified at all. Surprisingly, this sialylated molecule was the major product made and its synthesis simultaneously led to a preferential inhibition of glycolipid synthesis (Freeze et al, 1993) . We thought that the resemblance of Xyl/3MU products to G M3 might mean that other related glycosides could serve as more efficient acceptors for synthesizing glycosphingolipid-like molecules. To examine this, we incubated cells with various alkyl /6-glucosides and analyzed the products made, their effects on cells, and the enzymes responsible for their synthesis.
Results

Synthesis of small sugar chains on alkyl-/3-D-glucosides
We labeled melanoma cells with 3 H-galactose in the presence of octyl-/3-D-glucoside, octyl-a-D-glucoside, and octanoyl-N-methylglucamine (Mega 8) for 6 h. Essentially all of the products were secreted into the culture medium (data not shown). The products were purified from the medium using Q 8 cartridges. As shown in Table I , only cells incubated with GlqSOctyl made products above control values. Since the alkyl chain length might affect the amount or types of molecules made, we labeled cells with 3 H-galactose and varying concentrations of (C n H 2n +i)-/3-D-glucosides (n = 6 -9) and analyzed the labeled products as above. Figure 1 shows all /3-glucoside acceptors were labeled, but the best yield was obtained with Glc/3Octyl. Table II shows that 70-80% of the labeled molecules were bound by QAE-Sephadex and 85-98% of these were neutralized by digestion with A. ureafaciens sialidase (AUS). These anionic products were equally digested by the a2,3-and a2,8-specific Newcastle Disease Virus (NDV) sialidase (data not shown) indicating that the secreted glycoconjugates probably contained sialic acid in a2,3 linkage. The labeled material with a single negative charge could be . Synthesis of alkyl glycoconjugates by human melanoma cells using alkyl-/3-glucosides as alternate acceptors. Nearly confluent cells were incubated in the presence of different concentrations of nalkylglucosides for 5 h with 10 yu.Ci/ml 3 H-galactose for metabolic labeling Secreted glycoconjugates were isolated by applying the media to Qg-cartridges and eluting bound material with 100% methanol. All data were corrected for background values obtained with control cells not incubated with the alkylglucosides. batch eluted from C 18 cartridges with 40% methanol, but following AUS digestion, elution required 100% methanol. When this desialylated sample was analyzed by C18 reversed phase HPLC, it gave a single peak with the same retention time as the neutral products which did not bind to QAE-Sephadex (Figure 2 ). This indicated that the neutral species are precursors of the sialylated n-alkyl derivatives. When original neutral or neutralized samples were analyzed by amine adsorption HPLC, the molecules eluted in a position expected for a disaccharide (not shown). The radiolabeled galactose was released after digestion with Jack bean /3-galactosidase or Gal /31,4-specific galactosi- Material eluted with 100% methanol from C18 cartridges was applied to QAE columns. After washing to remove neutral material, aniomc components were eluted with 250 mM NaCl. The anionic fractions were digested with AUS. desalted with C18 cartridges, and applied again to QAE Sephadex to determine the percent of the anionic products which became neutral after sialidase digestion (AUS sensitive).
Structural analysis of the 3 H Gal labeled products
dase from Streptococcus pneumoniae, but not with /31,3-specific galactosidase from Xanthomonas manihotis showing that the single galactose is only in y31,4 linkage (WongMadden, et al, 1995) . A mixture of the sialylated products made on n-hexyl-, n-heptyl-, n-octyl-, and n-nonyl-/3-glucosides eluting with 40% methanol from C 18 -cartridges was digested with AUS and analyzed by reversed phase HPLC as shown in Figure  2B . As expected, shorter alkyl chain length resulted in an earlier elution from the C 18 column. From these data we conclude that melanoma cells can use a variety of alkyl-/3-glucosides as alternate acceptors for glycosylation to make a series of related compounds: First, a galactose is transferred in a /31,4 linkage, and most of this lactoside is further glycosylated with an a2,3 linked sialic acid.
GlcfiOctyl does not affect protein glycosylation or glycosphingolipid synthesis
Our previous studies showed that the synthesis of the sialylated /3-xylosides preferentially inhibited GSL synthesis in both melanoma and CHO cells (Freeze et al, 1993 H-galactose into GSL. There was also no change in the HPTLC pattern of GSLs labeled during the incubation. Thus, melanoma cells can use Glc/3Octyl at these concentrations as an alternate acceptor for glycosylation without affecting the biosynthesis of other cellular glycoconjugates.
Search for the galactosyltransferases involved in the synthesis of octyl /3 lactoside We next wanted to determine which /31.4 galactosyl transferase is responsible for the synthesis of Gal/81,4Glc/8Octyl. Since the structure of glucose and xylose are similar, one possible candidate is the GAG chain core specific /31.4 CHO cells were incubated with 3 H-galactose in the presence of xylosides and glucosides linked to different aglycones. The media were applied to C18-cartridges and bound molecules were eluted with 100% methanol. Radioactivity of eluted material is expressed as c.p.m./mg cell protein.
20"
Q. Analyses of secreted alkyl-glycoconjugates by C, g -HPLC Media from labeling experiments were applied to C l8 -cartridges and the bound glycoconjugates were eluted with 40% and 100% methanol The fractions were analyzed by C, 8 -HPLC using a linear water/ methanol gradient as described in the experimental procedure section. A, Analysis of A US digested and undigested glycoconjugates made on n-octyl-j3-D-Glc eluting with 40% methanol and neutral material eluting with 100% methanol from Qg cartridges. B, Equal amounts of n-hexyl-, octyl-, and nonylsaccharides and the double amount of nheptylsaccharide eluting with 40% from C ]g -cartndges were mixed after A US digestion and applied to the Q 8 columns.
761 cells, showing that the GAG chain specific galactosyltransferase is not involved in the synthesis of Gal/31,4Glc-jSOctyl. Two other Gal (31,4 transferases that might be responsible for the synthesis of Gal/31,4Glc/3Octyl are lactosylceramide(LacCer) synthase and UDP-Gal:GlcNAc /31,4 galactosyltransferase (GlcNAc GalT) which is used in N-linked oligosaccharide synthesis (Basu et al., 1987; Hill and Brew, 1975) . We established conditions of differential thermostability for these two /31,4 galactosyl transferases and then compared their loss of activity to that of the enzyme using Glc/3Octyl as an acceptor. Melanoma cell microsomal fractions were incubated for times up to 60 min at 47°C and portions withdrawn for assay. GlcNAc GalT and the enzyme responsible for the synthesis of Gal/31,4Glcj6Octyl were inactivated at similar rates ( Figure 3A ). By contrast, LacCer synthase was considerably more labile. These thermolability measurements were repeated using purified rat liver Golgi preparations which have considerably more LacCer activity. Figure 3B shows that the loss of Gal/31,4-Glc/3Octyl synthesis in rat liver Golgi preparations paralleled the loss of GlcNAc GalT activity (T m = 30 min), while the loss of LacCer synthase activity was much faster (r 1/2 = 10 min). Comparison of the inactivation of GlcNAc GalT and Glc/3Octyl GalT activities at 45, 47, and 50°C also showed superimposable inactivation kinetics. These data indicate that LacCer synthase is not the enzyme which galactosylates Glc/3Octyl and suggest that GlcNAc GalT may carry out the addition of Gal /31,4 to Glc/3Octyl in rat liver and in melanoma cells. However, these data cannot eliminate the possibility that this product could be made by another untested Gal /31,4 transferase with the identical thermolability as GlcNAc GalT.
galactosyl transferase which adds Gal residues to Xyl/3-MU(pNp) (Freeze et al, 1993) . We incubated wild type CHO cells and a CHO mutant cell line 761 which lacks this enzyme (Esko etal, 1987) with [ 3 H] Gal and Xyl/3MU, Glc/3Octyl, or with Glc/3MU as a negative control. Wildtype CHO cells secreted labeled products when incubated with the xyloside and Glc/3Octyl, but not when incubated with Glc/3MU (Table III) . As expected, CHO mutant 761 cells did not label /3-xyloside above the level of the controls. By contrast, Glc/3Octyl labeling was not affected in CHO
Galactosylatlon of GlcfiOctyl by purified GlcNAc fiGalT
We used purified bovine milk GlcNAc /Glc/S GalT to determine whether it could utilize Glc/3Octyl as a substrate. Further, we compared the ability of the purified bovine GlcNAc GalT and CHO cell microsomes to galactosylate GlqSOctyl, Glc/3MU, GlcNAc/3MU, and Xyl/3MU. All of these except Xyl/3MU were good substrates for the purified GlcNAc GalT with Vmax's ranging from about 50 to 80% of the value obtained using GlcNAc as acceptor (Table  IV) . The apparent K m values for Glc/3Octyl and Glc/3MU were larger than that for GlcNAc; but accurate determina- Time at 47 C (Min) Fig. 3 . Heat inactivation of galactosyltransferase activities. A, Melanoma cell lysate, 5 mg/ml cell protein, was preincubated at 47°C for varying times and galactosyltransferase assayed using GlcNAc
, and glucosylceramide (D-•) as substrates. B, Rat liver Golgi, 0.4 mg/ml protein, was preincubated at 47°C and enzyme activities were measured using 40 mM GlcNAc, 2 mM Glc/3Octyl, and 200 pM glucosylceramide as substrates. All enzyme assays were performed within a linear range of substrate concentration and time. The decay of the galactosyltransferase responsible for the synthesis of n-octyllactoside was identical using 2 mM and 40 mM GlcjSOctyl.
tion of these values was hindered by the detergent CMC of Glc/3Octyl (ca. 20-25 mM) and the limited solubility of Glc/3MU (ca. 20 mM). GlcNAqSMU was found to be a high affinity substrate for bovine GlcNAc GalT with an apparent K m of about 50 /u.M and a V mM of about 10 /xmol/ min/mg. No galactosylation of Xyl/3MU by bovine GlcNAc GalT could be detected. We compared these data for puri- (Schanbacher and Ebner, 1970) and 5.8 mM (Hill and Brew, 1975) . Specific activity of purified galactosyltransferase was 9.1 units/mg protein using glucose as substrate in the presence of 200 yug/ml a-lactalbumin at 30°C (Sigma Chemical Co. fied bovine GlcNAc GalT to those obtained from CHO cell microsomes using the same substrates. The Km's for GlcNAc and GlcNAc/3MU were similar for the enzymes from both sources while those for GlqSOctyl and Glc/3MU using CHO microsomes were slightly lower.
Inhibition of GlcfiOctyl galactosylation by GlcNAc and GlcNAcfiMU
The results presented above suggest that GlcNAc GalT may carry out the observed galactosylation of Glc/3Octyl in cultured cells and cell extracts. Furthermore, since GlcNAcy3MU is a higher affinity substrate for GlcNAc /31,4 GalT compared to GlcNAc, GlcNAc/3MU should compete out the galactosylation of GlqSOctyl at much lower concentrations than GlcNAc if the same galactosyltransferase acts on both substrates. Therefore, we assayed the rate of galactosylation of Glc/3Octyl (2 mM) by CHO cell microsomal membranes in the presence of increasing concentrations of GlcNAc or GlcNAqSMU. Figure 4 shows that GlcNAc and GlcNAqSMU competitively inhibit the galactosylation of Glc/3Octyl. Half-maximal inhibition occurs between 10 and 20 mM GlcNAc or at less than 100 pM GlcNAc/3MU; values consistent with their apparent K m values for GlcNAc GalT (see Table IV ). The galactosylation of GlqSOctyl was not inhibited by 100 mM GalNAc, Gal, Glc, Man, or 2-deoxyGlc (data not shown).
Discussion
We have shown here that human melanoma and Chinese hamster ovary cells can galactosylate and sialylate n-alkyl-(-glucosides. This appears to be fairly specific, since these cells will not use a similar compound containing an a-Glc, a related non-cyclic sugar molecule, octanoyl-N-methylglucamine (Mega 8), nor do they use Glc/3MU. Thus, both the carbohydrate and aglycone portions are involved in and important for glycosylation. The length of the alkyl The radiolabeled octyl-lactoside product was isolated by binding to C18 cartridges; for assays in the presence of GlcNAc/3MU, the LacNAc/3MU product was separated from the octyl-lactoside product by reverse phase HPLC.
chain appears to have only a minor influence on the amount and types of products made on these acceptors. These small differences probably reflect, in part, the efficiency of entry of the acceptor into the cells and/or the Golgi. The optimum chain length of C-8 in this study was also seen previously when various alkyl derivatives were used to prime glycosaminoglycan synthesis with /3-xylosides (Sobue et ai, 1987) . The C-6 to C-8 alkyl glycosides were not cytotoxic when used below 0.8-1.0 mM, although the C-9 glycoside showed some toxicity at this dose. All of the galactose appears to be added in /3-l,4 linkage to the glucose as shown by digestion with jack bean or S. pneumoniae /6-l,4 specific galactosidase. The /31,3 galactosidase from X. manlhotis did not cleave the galactose. The glycosylation is not restricted to the addition of a single galactose residue, but continues with the addition of an a2,3 linked sialic acid residue to the acceptor. Other studies (Pohlentz et ai, 1994) have shown that detergent treated rat liver Golgi adds both a2,3 and a2,6 linked sialic acids to Gal 131,4 Glc/3Octyl. At least a portion of these a2,3 linked sialic acids were added by SAT-1, the sialyl transferase responsible for synthesis of G M 3-All of the sialic acid added to octyl-lactoside by melanoma cells is sensitive to a2,3/2,8 specific sialidase from NDV and, therefore, do not have a2,6-linked sialic acid residues.
The sialylated products resemble ganglioside G M 3, Sia a2,3 Gal /31,4 Glq3-. The production of such similar structures by intact cells and isolated Golgi using different glycones and aglycones suggests a complex, and as yet undefined, set of interactions and contributions by each portion of the molecule. An example of the influence of the aglycone is illustrated by the recent work showing that low concentrations of various hydrophobic /3-xylosides can preferentially prime heparan sulfate or chondroitin sulfate chains (Lugemwa and Esko, 1991; Fritz et ai, 1994) . More recently, these studies have been extended by using cloned proteoglycan core proteins with amino acid replacements in the region near GAG chain addition site (Zhang and Esko, 1994) . Subtle changes in the peptide alters the proportion of heparan or chondroitin sulfate chains at that site. This is remarkable since the peptide sequence is thought to influence the addition of aGlcNAc or jSGalNAc as the fifth residue in the common core of GAG chains. Other studies also show considerable differences in the ability of the aglycone to alter specificity using artificial acceptors (Bergh and van den Eijnden, 1983; Brockhausen et ai, 1990; Dilulio and Bhavanandan 1995; Manzi et ai, 1995; Salimath et at, 1995) . Clearly, the aglycone or protein can determine both the initiation of glycosylation and influences the addition of sugars at some distance from the protein (Baenziger, 1994) .
We had previously shown that addition of Xyl/3MU to both melanoma and CHO cells inhibited glycosphingolipid synthesis by an unknown mechanism (Freeze et ai, 1993) , even though the galactose was added by the GAG-core specific j81,4 galactosyl transferase. Based on this finding and the absence of similar effects using Glc/3MU, we considered that GlqSOctyl might more closely resemble glucosylceramide, and also inhibit GSL synthesis. However, when used below toxic levels, there was no general or selective inhibition of GSL, glycoprotein, or proteoglycan or protein biosynthesis as measured using radiolabeled precursors.
An important issue was to identify which galactosyltransferase utilized Glc/3Octyl as a substrate. Previous studies showed that this acceptor could be galactosylated in Golgi preparations, but the enzyme was not identified (Senn et al., 1983) . We eliminated GAG-core specific /31,4 galactosyl transferase as a candidate by showing that synthesis was undiminished in a CHO cell mutant line which lacked this enzyme. The most likely other candidates were LacCer synthase and GlcNAc 01,4 galactosyl transferase. Although LacCer synthase has been purified, we were unable to obtain the purified LacCer synthase and/or the antibody made against it (Chatterjee et ai, 1992 and personal communication) . Instead, we relied on the thermolabilities of the two enzymes at 47°C to differentiate which might be responsible for the synthesis of Gal/31,4Glc/3Octyl. In both melanoma cells and rat liver Golgi, loss of galactosyl transferase activity using Glc/3Octyl as an acceptor was identical to that using GlcNAc as an acceptor. By contrast, LacCer synthase activity was considerably more labile at this temperature. These results indicated that LacCer synthase was not responsible for the galactosylation of Glc/3Octyl in these systems and suggested that GlcNAc /31,4 galactosyl transferase might be.
This hypothesis was bolstered by showing that purified GlcNAc /31,4 Gal transferase from milk could indeed use Glc/3Octyl as an acceptor with a Vmax similar to that seen using GlcNAc as substrate. Further, we have shown that GlcNAc/3MU is a high affinity substrate for GlcNAc/31,4 galactosyltransferase and that both GlcNAc and GlcNAcjSMU inhibit the galactosylation of Glc/3Octyl at concentrations near their K m values determined on purified GlcNAc GalT.
These results point to /3 1,4 galactosyl transferase as the enzyme that is responsible for the addition of the Gal residue to Glc/3Octyl. Clearly, the formation of this amount of product is not enough to compromise the synthesis of galactosylated N-linked oligosaccharides which also rely on this enzyme. We do not know which sialyl transferase is responsible for the addition of the a2,3 linked sialic acid to the galactose, but studies in rat liver show that some of the sialylation is due to SAT-I, the enzyme responsible for the synthesis of ganglioside G M 3 (Pohlentz et al., 1994) . If this is true, then clearly various "pathway specific" glycosyl transferases can cross these boundaries when allowed act on soluble acceptors in cells or static Golgi preparations. Our results and others (Brockhausen et al., 1990; Baenziger, 1994; Zhang and Esko, 1994; Dilulio and Bhavanandan, 1995; Salimath et al., 1995) create an emerging picture that invokes the complex influence of the aglycone in determining which glycosyl transferases will be active on a given substrate.
Material and methods
Materials
Newcastle disease virus (NDV) and Arthrobacter ureafaciens siahdase (AUS), /31,4 galactosidase from jack bean and S pneumoniae were purchased from Oxford Glycosystems, Xanthomonas manihotis /31,3 galactosidase from New England Biolabs. Bovine lactose synthetase and lactalbumin were obtained from Sigma. D-[2- 
Metabolic labeling of cells
UACC 903 melanoma cells were cultivated in DMEM containing 4.5 mg/ ml glucose, 2 mM glutamine, 100 U/ml penicilline G, 100 /xg/ml streptomycin sulfate, and 10% FBS (Freeze et al, 1993) , CHO wild type and CHO 761 cells in aMEM supplemented as above. Cultivation was performed in a humidified atmosphere at 5% CO 2 in air at 37°C. Medium was changed 1 d before harvest or metabolic labeling of the cells. Confluent and nearly confluent cells were harvested by trypsinization.
Medium of nearly confluent cells in 6 or 24 well tissue culture plates was replaced by DMEM (0.1 mg/ml glucose) containing different concentrations n-alkyl-glucosides (n = 6-10) as a or /3 anomer After 10 min preincubation, 10 /u,Ci/ml Na 2 H]galactose were added and incubated for 5 h. The percentage of floating cells was estimated, the medium was centrifuged at 800 x g. and the supernatant was stored at -20°C. Adherent cells were harvested and cell number and viability were estimated using Trypan blue exclusion. Cells were washed twice with ice cold CMF-PBS and stored at -20°C.
Estimation of protein and glycoprolein synthesis
Cell pellets were resuspended and a portion of each sample was precipitated with 5% ice cold TCA to measure [ 
GSL extraction and purification
Cell pellets were lyophihzed and extracted twice each with 0.5 to 1 ml chlorofornrmethanol (2.1), (1:1), and (1:2). Extracts were evaporated and resuspended in 0.1 M KC1 and applied to C18 cartridges equilibrated with 0.1 M KC1. After washing with 3 ml 0.1M KC1 and 3 x 3 ml water, GSL were eluted with 4 X 3 ml methanol. Eluates were evaporated, radioactivity measured and portions applied to an HPTLC plate. Chromatography was performed using chloroform:methanol:water (120:70:17, v:v:v) containing 2 mM CaCl 2 . Chromatograms were developed by fluorography.
Analyses of glycoconjugates
C,g Spice cartridges were pre-washed with 20 ml methanol, 20 ml, water and 20 ml 0.1 M KG. Cell culture media were applied to the columns, washed twice with 3 ml 0.1 M KC1, twice with 3 ml water or 0.1 M ammonium formate, and eluted with 40% methanol and 100 % methanol, 3 X 3 ml each (Freeze et al., 1993) . Fractions were collected separately and assayed for incorporated radioactivity. Alkyl glycoside products were lyophilized twice to eliminate residual ammonium formate. One thousand to 2000 c.p.m. of products eluted with 40% and 100% methanol from C18 cartridges or spin columns were dissolved in 2 mM Tris and applied to QAE Sephadex columns (0 5 ml bed volume) equilibrated with 2 mM Tris base. The columns were washed three times with 1.5 ml 2 mM Tris; charged molecules were eluted with 3 x 1.5 ml 70 mM NaCI , 150 mM, and 250 mM in 2 mM Tris (Freeze et al., 1993) .
Anionic molecules bound to QAE Sephadex were digested with 4 mU A. ureafaciens. sialidase in 0.1 M sodium acetate pH 5 or with 4 mU NDV sialidase in 50 mM sodium acetate pH 5.5 in 20 /AI volume. Neutral material was digested with 2 mU jack bean /31,4 galactosidase in 100 mM sodium acetate pH 6 or with Xanthomonas manihotis 01,3 galactosidase in 20 mM Tris-HCl pH 7.5, 50 mM NaCI, 0.1 mM EDTA in a final volume of 20 fj.\. All enzyme digestions were performed overnight at 37°C (Freeze et al., 1993; Etchison et al., 1995) .
Samples were applied to a reverse phase C18 column (4.6 X 25 mm LC 18, Supelco) equilibrated with distilled water. After 5 min washing with water, the column was eluted with a water/methanol gradient from 0 to 80% methanol over 75 min.
Glycosyltransferase assays
All /3-galactosyltransferase assays were performed in 65 mM cacodylate pH 7.35 (Zaccharias et al., 1994) containing 10 mM MnCl 2 , 0.2% Triton X-100 and 20 /iM IMP in a final volume of 50 ju.1. Assay blanks lacked exogenous acceptor.
The methods described by Basu et al. (1987) , and Senn el al. (1983) for assay of LacCer synthase were modified as follows: 30yttmole glucosylceramide dissolved in chloroform/methanol 2/1 v/v (1 /xg/ml) were mixed with 100 fig Triton X-100 dissolved in the same solvent (20 /ng/ml) in a microfuge tube. The solvent was evaporated and buffer, MnCl 2 , IMP and cell microsomes or Golgi enriched vesicles from rat liver equivalent to 5-20 fig protein were added. The reaction was started with 2 /xCi UDP-[ 3 H]galactose. Samples were vortexed vigorously and incubated at 37°C in a shaking water bath. The reactions were stopped after 1 or 2 h by adding 50 fi\ water and 500 /xl chlorofornrmethanol 2:1. After vortexing and centrifugmg, the aqueous upper phase was removed and the lower phase was washed again with 100 ix\ water After evaporation the content of the lower phases were dissolved in chlorofornrmethanol 2:1 v/v and applied to silica gel TLC plates on polyester. Chromatography was performed for 25 min using the same solvent as for HPTLC. As a reference standard, lactosylceramide was co-chromatographed in a separate lane and detected with orcinol (0.25% in 3 M H 2 SO 4 ). Lanes with samples were cut into 0.6 mm pieces and transferred to scintillation vials for counting radioactivity.
GlcNAc /31,4 galactosyltransferase activity in UACC melanoma cell homogenates, microsomes, and rat liver Golgi-enriched preparations were assayed as described by Aoiki el al. (1990) and Hayes et al. (1993) .
Heal inactivation of galactosyltransferase activity
Rat liver Golgi membranes were isolated exactly as described previously (Etchison et al., 1995) . Rat liver Golgi with 0.4 mg/ml protein in 50 mM sodium maleate/ HC1 pH 6.5 containing 1 mM MnCl 2 . 5 mM MgCl 2 . and 0.37 M sucrose were incubated in a 47°C water bath for 0. 2. 5. 10. 20. and 40 mm Samples were cooled on ice before galactosyltransferase activities were measured. Cell lysates from melanoma cells at 5 mg/ml were similarly incubated at 47°C and assayed as above.
